The biopharmaceutical industry is undergoing a significant transformation, driven by the need to develop and market novel therapies more quickly and cost-effectively. At the forefront of this revolution is WuXi Biologics, leveraging advanced Process Analytical Technology (PAT) to enhance real-time
Imagine a world where the devastating effects of Alzheimer's disease can be reversed through an innovative new drug. This scenario may soon become a reality, thanks to groundbreaking research from the Centre for Addiction and Mental Health (CAMH). The study investigates the impact of GL-II-73, an
The search for effective treatments for Parkinson's disease has been long and arduous, with researchers globally dedicating countless hours to uncover potential therapies. One promising candidate, exenatide, a GLP-1 drug traditionally used to treat Type 2 diabetes, recently underwent scrutiny in
The 2024 Biopharma Technology Landscape report by Benchling, a leading R&D cloud software company, reveals the transformative impact of artificial intelligence (AI) and automation on biopharma research and development (R&D). The report highlights how large biopharma companies are leveraging these
The biotech and healthcare sectors in the United Kingdom experienced a remarkable year in 2024, marked by substantial financial investments, significant trends, and notable challenges. Grounded in a report by the UK BioIndustry Association (BIA), this analysis delves into the pivotal investment
The recent moves by the Trump administration have cast a shadow of uncertainty over the biopharma sector, causing significant turmoil among companies relying on federal grants for clinical trials and drug development. The Office of Management and Budget (OMB) issued a memo on Monday that threatened
